The collaboration agreement with Regeneron to develop and commercialize fully-human therapeutic antibodies was presented by Mr. Jean-Claude Muller, Senior Vice President Administration and Resources, and Mr. Jean-Michel Lévy, Senior Vice President Business Development. The presentation was followed by a Q&A session.

• Find out more on the collaboration with Regeneron

The third quarter 2007 sales and earnings were reviewed by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

• Find out more on the third quarter 2007 sales and earnings

This meeting, intended for analysts and investors, included presentations on the research portfolio of our main therapeutic areas. There were two Q&A sessions.

• Find out more on the Research and Development meeting

The first half 2007 sales and earnings were reviewed by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

• Find out more on the first half 2007 sales and earnings

The rimonabant regulatory update was presented in English by Mr. Marc Cluzel, Senior Vice President Scientific and Medical Affairs and Mr. Jean-Pierre Lehner, Senior Vice President, Medical and Regulatory Affairs. The teleconference was followed by a Q&A session.

• Listen to the conference on Rimonabant

The first quarter 2007 Sales and earnings were reviewed by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

• Find out more on the first quarter 2007 sales and earnings

The introduction was made by Mr. Jean-François Dehecq (President). Mr. Gérard Le Fur (Chief Executive Officer) opened the meeting. 2006 Full-Year results were reviewed successively by Mr. Hanspeter Spek (Executive Vice President Pharmaceutical Operations), Mr. Wayne Pisano (Senior Vice President Commercial Operations & Corporate Strategy, sanofi pasteur) and Mr. Jean-Claude Leroy (Executive Vice President CFO). Mr. Marc Cluzel (Senior Vice President Science and Medical Affairs) and Mr. Pierre Chancel (Senior Vice President Global Marketing) presented the Commercial Operations and Research & Development. The presentation was followed by a Q&A session.

• Find out more on the 2006 full-year results